CSI Market
Sign In | Register

Entrada Therapeutics Inc (TRDA) Annual Balance Sheets

Annual · GAAP · USD millions
Access TRDA quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Entrada Therapeutics Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent90.39
Cash & Short-term Investments90.00
Other Current Assets207.14
Prepaid Expense And Other Assets Current8.72
Total Current Assets306.25
Equipment/Property/Plant Net7.31
Other Assets, Noncurrent63.81
Debt Securities Available For Sale Excluding Accrued Interest205.30
Restricted Cash Noncurrent3.29
Operating Lease Right Of Use Asset60.45
Total Assets377.38
Liabilities
Accounts Payable, Current AC2.29
Accrued Liabilities, Current AC17.68
Other Liabilities, Current4.14
Taxes Payable, Current, Total0.00
Deferred Revenue, Current DE0.34
Total Current Liabilities24.45
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent46.79
Operating Lease Liability Current4.14
Operating Lease Liability Noncurrent46.79
Total Liabilities71.25
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock578.57
Retained Earnings / Accumulated Deficit-273.09
Other Equity0.65
Common Stockholder's Equity306.13
Total Stockholder's Equity306.13
Liabilities & Stockholder's Equity377.38
4 historic quarters locked

Sign in to unlock the full Entrada Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Entrada Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: trda-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001689375-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License